37 pharmaceutical companies enter the top 500 listed companies in China

Recently, the latest list of China's top 500 listed companies by market value in 2020 was released According to the statistics of 21 data news laboratory, as of January 1, 2020, there are 7343 Chinese listed companies listed on 15 exchanges around the world, such as Shanghai, Shenzhen, Hong Kong and New York It is understood that this year, the market value threshold of the top 500 has reached a new high, 7.7 billion yuan higher than the previous year 001pt.com, the first electronic data exchange platform, found that 37 enterprises in the pharmaceutical and biological industry have entered the latest China's top 500 listed companies by market value in 2020 Among them, Hengrui pharmaceutical ranked 25th in the total list with 387.1 billion yuan, ranking first in the pharmaceutical and biological industry Meirui Pharmaceutical (221.1 billion yuan, ranked 65) and Wuxi Pharmaceutical (150 billion yuan, ranked 102) ranked second and third in the pharmaceutical industry The top ten enterprises in the pharmaceutical and biological industry with market value include Hansen Pharmaceutical (134.3 billion yuan, ranking 112), China biopharmaceutical (122.9 billion yuan, ranking 133), aer Ophthalmology (122.5 billion yuan, ranking 134), Yaoming biological (114.3 billion yuan, ranking 142), Yunnan Baiyao (114.2 billion yuan, ranking 143), Shiyao group (103.8 billion yuan, ranking 159), Ali health (97 billion yuan, ranking 1) 66) From the perspective of market value change, there are 10 enterprises with an increase of more than 90%, which are Changchun hi tech (up 203.85%), Kangtai Biology (up 147.92%), tiger medicine (up 121.37%), Tongce medical (up 115.99%), China biopharmaceutical (up 115.64%), Yaoming Biology (up 112.18%), Pingan good doctor (up 110.58%), Hengrui medicine (up 99.29%) ）, antuobio (up 97.14%), Aier Ophthalmology (up 95.51%) In terms of new faces, there are three new pharmaceutical and biological enterprises in the list, Hansen pharmaceutical, Huaxi biological (40 billion yuan, 416), KANGLONG Huacheng (42.6 billion yuan, 426) In terms of geographical distribution, Jiangsu and Shanghai have the largest number of pharmaceutical enterprises in the top 500 listed companies with market value, with 5 each, followed by 4 in Beijing, Guangdong, Zhejiang and Hong Kong, 2 in Henan, Shandong and Yunnan, and 1 in Fujian, Hunan, Jilin, Sichuan and Chongqing Attached with the latest list of China's top 500 listed companies by market value in 2020 (pharmaceutical and biological industry): Source: Medical observer network Author: saner